Business Standard

Without whole-genome sequencing, a treatable TB epidemic is a challenge

HaystackAnalytics, an IIT Bombay-incubated company working in the area of genomics using big data has created a comprehensive drug resistance test for tuberculosis (TB)

Dr Chaitali Nikam
Premium

Dr Chaitali Nikam

Sohini Das
HaystackAnalytics, an IIT Bombay-incubated company working in the area of genomics using big data has created a comprehensive drug resistance test for tuberculosis (TB). In an emailed interview with Sohini Das, Dr Chaitali Nikam, Director-infexn, HaystackAnalytics, explains why whole-genome sequencing is critical for eliminating TB from India. Edited excerpts.
 
Why is whole-genome Sequencing (WGS) critical for tackling the TB crisis in India?

TB is not only a global public health concern, with an estimated 10 million people suffering from the disease and 1.4 million people having died in 2019, but it also has societal consequences. India has the highest TB

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in